Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation
- PMID: 34074830
- DOI: 10.14309/ajg.0000000000001149
Exploratory Comparative Effectiveness Trial of Green Kiwifruit, Psyllium, or Prunes in US Patients With Chronic Constipation
Abstract
Introduction: Psyllium and prunes are proven treatments for chronic constipation (CC). Asian studies suggest that kiwifruit may also benefit CC symptoms. We report a partially randomized, comparative effectiveness trial evaluating kiwifruit, psyllium, and prunes in US patients with CC.
Methods: Adults with CC at a US medical center were randomized to 3 natural treatments. Eligible patients had ≤3 complete spontaneous bowel movements (CSBMs) per week and were partially randomized to green kiwifruit (2/d), prunes (100 g/d), or psyllium (12 g/d) for 4 weeks. The primary endpoint was the proportion of patients in each group reporting an increase of ≥1 CSBM per week compared with baseline for at least 2 of 4 treatment weeks. Key secondary outcomes included stool frequency, stool consistency, and straining assessed daily. Treatment satisfaction and adverse events (AEs) were also measured. Standard statistical methods were used, and a P < 0.05 was considered significant.
Results: Seventy-nine patients with CC (mean age = 42.7 years, 87% female, and 77% white) were partially randomized. Complete data were available for 75 patients (kiwifruit 29, prunes 24, and psyllium 22). For the primary endpoint, proportions of CSBM responders were similar for the treatments. For secondary outcomes comparing treatment weeks 3 and 4 to baseline, there was a significant increase in weekly CSBM rate with all 3 treatments (P ≤ 0.003); stool consistency significantly improved with kiwifruit (P = 0.01) and prunes (P = 0.049); and straining significantly improved with kiwifruit (P = 0.003), prunes (P < 0.001), and psyllium (P = 0.04). Patients randomized to the kiwifruit group reported significant improvement in bloating scores (P = 0.02). AEs were most common with psyllium and least common with kiwifruit. At the end of treatment, a smaller proportion of patients were dissatisfied with kiwifruit compared with prunes or psyllium (P = 0.02).
Discussion: Kiwifruit, prunes, and psyllium improve constipation symptoms in patients with CC. Kiwifruit was associated with the lowest rate of AEs and dissatisfaction with therapy.
Trial registration: ClinicalTrials.gov NCT00356952 NCT03569527.
Copyright © 2021 by The American College of Gastroenterology.
Similar articles
-
Kiwifruit and Kiwifruit Extracts for Treatment of Constipation: A Systematic Review and Meta-Analysis.Can J Gastroenterol Hepatol. 2022 Oct 6;2022:7596920. doi: 10.1155/2022/7596920. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 36247043 Free PMC article. Review.
-
Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults-A Randomized Clinical Trial.Nutrients. 2022 Oct 6;14(19):4146. doi: 10.3390/nu14194146. Nutrients. 2022. PMID: 36235798 Free PMC article. Clinical Trial.
-
The effect of 'Zesy002' kiwifruit (Actinidia chinensis var. chinensis) on gut health function: a randomised cross-over clinical trial.J Nutr Sci. 2019 May 3;8:e18. doi: 10.1017/jns.2019.14. eCollection 2019. J Nutr Sci. 2019. PMID: 31080591 Free PMC article. Clinical Trial.
-
Randomised clinical trial: mixed soluble/insoluble fibre vs. psyllium for chronic constipation.Aliment Pharmacol Ther. 2016 Jul;44(1):35-44. doi: 10.1111/apt.13647. Epub 2016 Apr 29. Aliment Pharmacol Ther. 2016. PMID: 27125883 Free PMC article. Clinical Trial.
-
Systematic review: the effect of prunes on gastrointestinal function.Aliment Pharmacol Ther. 2014 Oct;40(7):750-8. doi: 10.1111/apt.12913. Epub 2014 Aug 11. Aliment Pharmacol Ther. 2014. PMID: 25109788 Review.
Cited by
-
The Impact of Nutritional Therapy on Gastrointestinal Motility in Older Adults.Healthcare (Basel). 2023 Oct 26;11(21):2829. doi: 10.3390/healthcare11212829. Healthcare (Basel). 2023. PMID: 37957974 Free PMC article. Review.
-
2022 Seoul Consensus on Clinical Practice Guidelines for Functional Constipation.J Neurogastroenterol Motil. 2023 Jul 30;29(3):271-305. doi: 10.5056/jnm23066. J Neurogastroenterol Motil. 2023. PMID: 37417257 Free PMC article. Review.
-
Effect of fruit intake on functional constipation: A systematic review and meta-analysis of randomized and crossover studies.Front Nutr. 2022 Oct 6;9:1018502. doi: 10.3389/fnut.2022.1018502. eCollection 2022. Front Nutr. 2022. PMID: 36276840 Free PMC article.
-
Kiwifruit and Kiwifruit Extracts for Treatment of Constipation: A Systematic Review and Meta-Analysis.Can J Gastroenterol Hepatol. 2022 Oct 6;2022:7596920. doi: 10.1155/2022/7596920. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 36247043 Free PMC article. Review.
-
Two Gold Kiwifruit Daily for Effective Treatment of Constipation in Adults-A Randomized Clinical Trial.Nutrients. 2022 Oct 6;14(19):4146. doi: 10.3390/nu14194146. Nutrients. 2022. PMID: 36235798 Free PMC article. Clinical Trial.
References
-
- Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis. Am J Gastroenterol 2011;106:1582–91; quiz 1581, 1592.
-
- Heidelbaugh JJ, Stelwagon M, Miller SA, et al. The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden. Am J Gastroenterol 2015;110:580–7.
-
- Peery AF, Crockett SD, Murphy CC, et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2018. Gastroenterology 2019;156:254–72 e11.
-
- Camilleri M, Ford AC, Mawe GM, et al. Chronic constipation. Nat Rev Dis Primers 2017;3:17095.
-
- Ford AC, Moayyedi P, Chey WD, et al. American College of Gastroenterology monograph on management of irritable bowel syndrome. Am J Gastroenterol 2018;113:1–18.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical